Lopid and Aranesp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lopid (gemfibrozil) and Aranesp (darbepoetin alfa). Common drug interactions include renal failure acute among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Lopid and Aranesp. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Lopid?

Lopid has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 9,700 Lopid users. Check the latest studies of Lopid.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

On Jul, 07, 2026

38 people who take Lopid and Aranesp together, and have interactions are studied.

What are the common drug interactions of Lopid and Aranesp, by gender? *:

female:

Renal failure acute (rapid kidney dysfunction)
Ankle fracture
Blindness transient (sudden loss of vision)
Blood creatinine increased
Blood urea increased
Bone density decreased
Chronic kidney disease
Death
Dizziness
Emotional distress

male:

Renal failure (kidney dysfunction)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Diarrhoea
Epistaxis (bleed from the nose)
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
General physical health deterioration (weak health status)
Hypotension (abnormally low blood pressure)
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)

What are the common drug interactions of Lopid and Aranesp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Hyperthermia (body temperature greatly above normal)
Pyrexia (fever)

40-49:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Depression
Erythema (redness of the skin)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Oedema peripheral (superficial swelling)
Abdominal pain
Antiphospholipid syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss)
Anxiety
Arteriospasm coronary (spasm of the large- or medium-sized coronary arteries)
Arthralgia (joint pain)

50-59:

Quadriparesis (muscle weakness affecting all four limbs)
Rash pruritic (redness with itching)
Skin hypertrophy (skin cells enlarges)
Skin lesion
Skin tightness
Tooth loss
Vomiting
White blood cell count decreased
Bacteriuria (presence of bacteria in urine)
Chest pain

60+:

Blood creatinine increased
Renal failure (kidney dysfunction)
Red blood cell count decreased
Renal failure acute (rapid kidney dysfunction)
Abdominal discomfort
Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
Anaemia (lack of blood)
Aortic arteriosclerosis (hardening of the aortic arteries)
Aseptic necrosis bone
Asthenia (weakness)

What are the existing conditions these people have? *

Chronic Renal Failure (kidney failure): 6 people, 15.79%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 13.16%
Nuclear Magnetic Resonance Imaging Brain: 3 people, 7.89%
Metastases To Bone (cancer spreads to bone): 2 people, 5.26%
Hiv Infection: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Lopid and Aranesp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously